Found: 11
Select item for more details and to access through your institution.
Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody‐dependent cell‐mediated cytotoxicity and complement‐dependent cytotoxicity.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
The relevance of tumor target expression levels on IgA-mediated cytotoxicity in cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03824-0
- By:
- Publication type:
- Article
Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 1, p. 1, doi. 10.1007/s00262-023-03600-6
- By:
- Publication type:
- Article
Characterization of human Fc alpha receptor transgenic mice: comparison of CD89 expression and antibody-dependent tumor killing between mouse strains.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 3063, doi. 10.1007/s00262-023-03478-4
- By:
- Publication type:
- Article
Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.01701
- By:
- Publication type:
- Article
Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00704
- By:
- Publication type:
- Article
Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3405, doi. 10.3390/cancers15133405
- By:
- Publication type:
- Article
Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1178817
- By:
- Publication type:
- Article
MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL.
- Published in:
- Cell Death & Disease, 2016, v. 7, n. 8, p. e2345, doi. 10.1038/cddis.2016.237
- By:
- Publication type:
- Article
Effective, Long-Term, Neutrophil Depletion Using a Murinized Anti-Ly-6G 1A8 Antibody.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 21, p. 3406, doi. 10.3390/cells11213406
- By:
- Publication type:
- Article
Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions.
- Published in:
- Cancer Science, 2021, v. 112, n. 8, p. 3029, doi. 10.1111/cas.14999
- By:
- Publication type:
- Article